Karen L. Tubridy, Chief Development Officer at Eleven Biotherapeutics, Inc. (EBIO), sold 4,372 shares at $2.08 ($9K) on 2016-06-27, disclosed to the SEC on 2016-06-29.
Open-market sale of $9k EBIO by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |